Overview of Photodynamic Therapy (PDT): PDT is a treatment for choroidal pathologies, involving intravenous infusion of a photosensitizing agent (e.g., Verteporfin) followed by targeted light exposure at 689 nm. Standard…

  Laser Fundamentals Definition: Laser = Light Amplification by Stimulated Emission of Radiation. Components: Optical Resonator: Comprises mirrors forming a cavity where light circulates. Gain Medium: Amplifies light (e.g., laser…

Study Overview Purpose: To identify underlying genetic diagnoses (familial exudative vitreoretinopathy [FEVR] or telomere biology disorders [TBD]) in preterm infants with atypical retinopathy of prematurity (ROP) using genetic testing and…

Study Overview Purpose: Evaluates the safety of same-day bilateral intravitreal anti-vascular endothelial growth factor (anti-VEGF) injections in preterm infants with retinopathy of prematurity (ROP). Design: Retrospective, multicenter case series involving…

  Central Serous Chorioretinopathy (CSCR) Overview: CSCR is characterized by subretinal fluid accumulation due to increased choriocapillaris blood flow and permeability, often linked to elevated cortisol or corticosteroid use.  Emerging…

Definition and Classification of Type 3 MNV: Type 3 macular neovascularization (MNV) is a distinct form of neovascular age-related macular degeneration (AMD) originating from the retinal vasculature, specifically the deep…

Study Overview: Phase 3, multicenter, randomized clinical trial (Pavilion) evaluating the Port Delivery System (PDS) with ranibizumab (100 mg/mL, refilled every 36 weeks, PDS Q36W) versus monitoring (control) in moderately…

Study Overview: Retrospective cross-sectional study comparing choroidal layer thickness beneath flat irregular pigment epithelial detachments (FIPEDs) in uncomplicated chronic central serous chorioretinopathy (uCSC) versus CSC complicated by type 1 macular…

Study Overview: Post hoc analysis of the DRCR Retina Network Protocol S randomized clinical trial comparing ranibizumab (anti-VEGF) versus panretinal photocoagulation (PRP) for proliferative diabetic retinopathy (PDR). Objective: Evaluate long-term…

Overview of Isolated Retinal Neovascularization (IRNV): IRNV, previously termed "popcorn" lesions, is a common finding in stage 2 and 3 retinopathy of prematurity (ROP), visualized as neovascular tufts posterior to…

Overview of Age-related Macular Degeneration (AMD): AMD: Leading cause of irreversible vision loss in elderly; affects 196 million globally, projected to reach 288 million by 2040. Non-exudative (dry) AMD: Majority…

Overview of GLP-1 Receptor Agonists: Glucagon-like peptide-1 (GLP-1) receptor agonists (e.g., semaglutide, dulaglutide, liraglutide) are incretin-based drugs used for type 2 diabetes mellitus (T2DM) and obesity management. Act on pancreatic…

Epidemiology and Burden: Age-related macular degeneration (AMD) affects ~20 million in the US; diabetic retinopathy (DR) affects over 11 million. AMD costs ~$47 billion annually to US employers and health…

Definition and Epidemiology: Retinopathy of Prematurity (ROP) is a multifactorial retinal vascular disorder affecting preterm infants, previously known as retrolental fibroplasia. Incidence in the US increased from 14.70% to 19.88%…

  Overview of Proliferative Diabetic Retinopathy (PDR): PDR is the most advanced form of diabetic eye disease, affecting patients with type 1 and type 2 diabetes mellitus. Treatment options include…